Please login to the form below

Not currently logged in
Email:
Password:

meningitis B

This page shows the latest meningitis B news and features for those working in and with pharma, biotech and healthcare.

Declining childhood vaccination rates ring alarm bells in England

Declining childhood vaccination rates ring alarm bells in England

The figures also showed decreases in coverage of the 5-in-1 vaccine – which protects against diphtheria, tetanus, pertussis (whooping cough), polio and Haemophilus influenza type b (which can cause meningitis) – ... Sheuli Porkess. She pointed to the

Latest news

  • GSK's Shingrix sails through FDA advisory committee GSK's Shingrix sails through FDA advisory committee

    EvaluatePharma's latest World Preview report predicts that Shingrix will bring in worldwide product sales of $1.13bn in 2022, adding another blockbuster to GSK's vaccine portfolio alongside meningitis B

  • GSK makes case for revaccination with Shingrix GSK makes case for revaccination with Shingrix

    EvaluatePharma's latest World Preview report predicts that Shingrix will bring in worldwide product sales of $1.13bn in 2022, adding another blockbuster to GSK's vaccine portfolio alongside meningitis B

  • Pfizer wins EU approval for MenB vaccine Trumenba Pfizer wins EU approval for MenB vaccine Trumenba

    Pfizer's Trumenba has been approved for the prevention of meningitis B (MenB) in Europe, laying the ground for the first alternative to GlaxoSmithKline's Bexsero, supplies of which have been ... The UK-based Meningitis Research Foundation said it

  • Bexsero halved UK meningitis B cases in first year, says study Bexsero halved UK meningitis B cases in first year, says study

    GlaxoSmithKline's meningitis B vaccine Bexsero has had a dramatic impact on meningitis B cases in the UK, according to a real-world evidence study. ... provides reassurance to parents who have already vaccinated their children or wish to help protect

  • Pfizer posts positive Trumenba vaccine data Pfizer posts positive Trumenba vaccine data

    Pfizer's Trumenba vaccine for meningitis B has shown favourable results in two phase III trials. ... The serogroup B strain accounted for over 30% of around 500 reported cases of meningitis in the US in 2013.

More from news
Approximately 5 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • Pharma deals during April 2014 Pharma deals during April 2014

    franchise. The icing on the cake is Bexsero for the prevention of meningitis B, which has EU approval and orphan drug designation in the US. Also included in the meningitis “goodie ... training. The Liat Influenza A/B Assay, the first test available

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • UK vs US: what makes a successful immunisation programme?

    My challenge started when my daughter Anna was born. The Hepatitis B vaccine is given at birth in the US, and at the time, this was not a part of the ... The Meningitis B vaccine is unique to the UK and since we live in the UK that was easy to get.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics